EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieQuerschnittstudieOpen Access · CC BY-NC 4.0

Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire

Shinta Trilaksmi Dewi, Nyoman Suryawati, Niken Indrastuti, Dorra Bouazzi, Cecilia E Medianfar, Robin Christensen, Gregor B E Jemec, Nisha S Chandran, Miranti Pangastuti, Aryani Adji, Gardenia Akhyar, Nopriyati Nopriyati und 2 weitere

Dermatology · 2025

DOI: 10.1159/000539705 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Dermatology, 2025. Verfasst von Shinta Trilaksmi Dewi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito Central General Hosp…. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Studies on the prevalence of hidradenitis suppurative (HS) in Southeast Asia are scarce, and no studies have been conducted in Indonesia. This study aimed to calculate the prevalence of HS in Indonesia and validate this questionnaire in our population as part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative.

Methods

This multicenter cross-sectional study was conducted at 7 teaching hospitals in western and central Indonesia from December 2022 to June 2023. A total of 3,237 healthy adults accompanying patients in the outpatient clinics consented to participate. Physicians or nurses delivered the validated screening questionnaire, and photos of the axilla and groin were taken from screen-positive individuals and 10% of the screen-negative individuals. The dermatologist examined the clinical photos to confirm the diagnosis of HS.

Results

The prevalence of HS in our study population was 0.43% (14/3,237; with 95% confidence interval [CI]: 0.26%–0.72%), and there was no significant difference in gender, age, body mass index (BMI), and smoking habit between the HS and non-HS groups. In the HS group, males and females were equally affected, with the median age being 29 years with interquartile range (IQR: 24.8–38.5), median BMI of 23.0 (IQR: 21.1–26.4), and 28.6% being smokers. The screening questionnaire showed a sensitivity of 0.43 (6/14; 95% CI: 0.18–0.17), specificity of 0.94 (362/386; 95% CI: 0.91–0.96), positive predictive value of 0.20 (6/30; 95% CI: 0.08–0.39), and negative predictive value of 0.98 (362/370; 95% CI: 0.96–0.99).

Conclusion

The prevalence of HS in Indonesia is 0.43%, slightly lower than those reported in other Southeast Asian countries. Age, gender, BMI, and smoking habits were not risk factors for HS in our population. The questionnaire is moderately accurate for screening HS but remains valuable in detecting around 50% of undiagnosed cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaMass ScreeningHumansIndonesiaCross-Sectional StudiesMaleFemaleAdultPrevalenceSurveys and QuestionnairesMiddle AgedYoung Adult

Stichwörter der Autor:innen

Hidradenitis suppurativaIndonesiaMulticenterPrevalenceQuestionnaire

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito Central General Hospital, Yogyakarta, Indonesia.
  • Department of Dermatology and Venereology, Faculty of Medicine Udayana University/Prof. Dr. I.G.N.G. Ngoerah Central General Hospital, Denpasar, Indonesia.
  • Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.

Zitieren

APA

Dewi, S. T., Suryawati, N., Indrastuti, N., Bouazzi, D., Medianfar, C. E., Christensen, R., Jemec, G. B. E., Chandran, N. S., Pangastuti, M., Adji, A., Akhyar, G., Nopriyati, N., Hazlianda, C. P., & Febriana, S. A. (2025). Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire. Dermatology. https://doi.org/10.1159/000539705

Vancouver

Dewi ST, Suryawati N, Indrastuti N, Bouazzi D, Medianfar CE, Christensen R, et al. Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire. Dermatology. 2025. doi:10.1159/000539705

BibTeX
@article{Dewi2025,
  author = {Dewi, Shinta Trilaksmi and Suryawati, Nyoman and Indrastuti, Niken and Bouazzi, Dorra and Medianfar, Cecilia E and Christensen, Robin and Jemec, Gregor B E and Chandran, Nisha S and Pangastuti, Miranti and Adji, Aryani and Akhyar, Gardenia and Nopriyati, Nopriyati and Hazlianda, Cut Putri and Febriana, Sri Awalia},
  title = {Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire},
  journal = {Dermatology},
  year = {2025},
  doi = {10.1159/000539705}
}
Kostenlos starten →